Showing 2,421 - 2,440 results of 20,793 for search '"therapy"', query time: 0.12s Refine Results
  1. 2421

    Symptomatic vigabatrin‐associated MRI toxicity is associated with simultaneous hormonal therapy among patients with infantile spasms by Rujuta Sathe, Gyaneshwar Shrestha, Aria Terango, David Tabibzadeh, Rajsekar R. Rajaraman, Hiroki Nariai, Shaun A. Hussain

    Published 2025-02-01
    “…Whereas asymptomatic VABAM appears to be dose‐dependent, symptomatic VABAM is possibly associated with co‐administration of vigabatrin and hormonal therapy (i.e., corticosteroids or adrenocorticotropic hormone). …”
    Get full text
    Article
  2. 2422

    Inferior Vena Cava Filter Placement during Pregnancy: An Adjuvant Option When Medical Therapy Fails by Sara Valadares, Fátima Serrano, Rita Torres, Augusta Borges

    Published 2013-01-01
    “…At 15th week of gestation, following an acute deep venous thrombosis of the right inferior limb, anticoagulant therapy with low-molecular-weight heparin (LMWH) was instituted without improvement in her clinical status. …”
    Get full text
    Article
  3. 2423
  4. 2424

    Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies by Linghui Meng, Shengyang Liu, Jinfeng Luo, Yanyi Tu, Tao Li, Ping Li, Jinzhuang Yu, Li Shi

    Published 2025-12-01
    “…Recent studies have highlighted the potential of antioxidant therapies to mitigate oxidative stress and restore homeostasis, offering promising avenues for alleviating symptoms in these diseases. …”
    Get full text
    Article
  5. 2425

    POTENCY OF SOURSOP LEAF EXTRACT AND CURCUMIN WITH MAGNETIC AND MUCUS-PENETRATING NANOPARTICLE AS COLORECTAL CANCER ALTERNATIVE THERAPY by Faiza Rahma Ebnudesita, Ayik Rochyatul Jannah, Savira Butsainah Dienanta, Reny I'tishom

    Published 2022-03-01
    “…Currently, resection and adjuvant chemotherapy are the main therapies for colorectal cancer. Resection is an invasive procedure and chemotherapy often causes side effects due to non-specific work targets. …”
    Get full text
    Article
  6. 2426
  7. 2427
  8. 2428
  9. 2429
  10. 2430

    Preclinical assessment of splicing modulation therapy for ABCA4 variant c.768G>T in Stargardt disease by Dyah W. Karjosukarso, Femke Bukkems, Lonneke Duijkers, Tomasz Z. Tomkiewicz, Julia Kiefmann, Andrei Sarlea, Sander Bervoets, Irene Vázquez-Domínguez, Laurie L. Molday, Robert S. Molday, Mihai G. Netea, Carel B. Hoyng, Alejandro Garanto, Rob W. J. Collin

    Published 2025-01-01
    “…Considering the high prevalence of this variant, a substantial number of patients are likely to benefit from a successful further development and implementation of this therapy.…”
    Get full text
    Article
  11. 2431
  12. 2432
  13. 2433
  14. 2434
  15. 2435

    Colchicine combination therapy increases treatment tolerance in patients with arthritis: A systematic review and meta-analysis. by Changwei Zhao, Xiaogang Hao, Wenjun Cai, Ling-Feng Zeng, Wenhai Zhao, Xiangxin Li

    Published 2024-01-01
    “…<h4>Conclusion</h4>Compared with colchicine alone, combination therapy improves patients' quality of life without increasing the incidence of adverse events.…”
    Get full text
    Article
  16. 2436
  17. 2437
  18. 2438
  19. 2439

    Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A2 α for targeted cancer therapy by Felicity J. Ashcroft, Asimina Bourboula, Nur Mahammad, Efrosini Barbayianni, Astrid J. Feuerherm, Thanh Thuy Nguyen, Daiki Hayashi, Maroula G. Kokotou, Konstantinos Alevizopoulos, Edward A. Dennis, George Kokotos, Berit Johansen

    Published 2025-01-01
    “…Targeting their production by inhibiting Group IVA cytosolic phospholipase A2 (cPLA2α) offers a promising approach for cancer therapy. In this study, we synthesize a second generation of thiazolyl ketone inhibitors of cPLA2α starting with compound GK470 (AVX235) and test their in vitro and cellular activities. …”
    Get full text
    Article
  20. 2440